Cell death prevention, mitogen-activated protein kinase stimulation, and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptides
Open Access
- 29 April 1997
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 94 (9) , 4778-4781
- https://doi.org/10.1073/pnas.94.9.4778
Abstract
Prosaposin, the precursor of saposins A, B, C, and D, was recently identified as a neurotrophic factor. Herein prosaposin was found to increase sulfatide concentrations in primary and transformed Schwann cells (iSC) and oligodendrocytes (differentiated CG4 cells). Of the four mature saposins, only saposin C was found to increase sulfatide concentrations in these cell types. A similar result was obtained by using peptides (prosaptides) encompassing the neurotrophic sequence located in the saposin C domain. Dose–response curves demonstrated maximal enhancement by saposin C and prosaptides at low nanomolar concentrations (5–10 nM). The increase in sulfatide concentration by a 14-mer prosaptide, TX14(A), in CG4 oligodendrocytes was about 3-fold greater than in primary Schwann cells. A mutant prosaptide with a single amino acid replacement of Asn → Asp was inactive. Prosaptides did not induce cell proliferation of primary Schwann cells, iSC cells, or CG4 oligodendrocytes but nanomolar concentrations of prosaptides prevented cell death of iSC cells and CG4 oligodendrocytes. Immunoblot analysis demonstrated that phosphorylation of both mitogen-activated protein kinase p-42 and p-44 isoforms were enhanced 3- to 5-fold after 5 min of treatment with prosaptides at concentrations of 1–5 nM. These findings suggest that prosaposin and prosaptides bind to a receptor that initiates signal transduction to promote myelin lipid synthesis and prolong cell survival in both Schwann cells and oligodendrocytes. Prosaposin may function as a myelinotrophic factor in vivo during development and repair of myelinated nerves explaining the deficiency of myelin observed in prosaposin-deficient mice and humans.Keywords
This publication has 18 references indexed in Scilit:
- Induction of MAPK Phosphorylation by Prosaposin and Prosaptide in PC12 CellsBiochemical and Biophysical Research Communications, 1996
- Targeted disruption of the mouse sphingolipid activator protein gene: a complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipidsHuman Molecular Genetics, 1996
- Prosaposin Facilitates Sciatic Nerve Regeneration In VivoJournal of Neurochemistry, 1996
- Functional Organization of Saposin CJournal of Biological Chemistry, 1996
- Differentially expressed genes after peripheral nerve injuryJournal of Neuroscience Research, 1995
- Protection by Prosaposin Against Ischemia-Induced Learning Disability and Neuronal LossBiochemical and Biophysical Research Communications, 1994
- Isolation of activated adult schwann cells and a spontaneously immortal schwann cell cloneJournal of Neuroscience Research, 1992
- CG‐4, A new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type‐2 astrocytesJournal of Neuroscience Research, 1992
- Sphingolipid activator protein deficiency in a 16-week-old atypical Gaucher disease patient and his fetal sibling: Biochemical signs of combined sphingolipidosesEuropean Journal of Pediatrics, 1989
- RGD-containing peptides inhibit the synthesis of myelin-like membrane by cultured oligodendrocytes.The Journal of cell biology, 1988